341 related articles for article (PubMed ID: 33379141)
1. Anti-Tumor Activity of
Menegazzi M; Masiello P; Novelli M
Antioxidants (Basel); 2020 Dec; 10(1):. PubMed ID: 33379141
[TBL] [Abstract][Full Text] [Related]
2. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
Galeotti N
J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
[TBL] [Abstract][Full Text] [Related]
3. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
[TBL] [Abstract][Full Text] [Related]
4. St. John's wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity.
Novelli M; Beffy P; Menegazzi M; De Tata V; Martino L; Sgarbossa A; Porozov S; Pippa A; Masini M; Marchetti P; Masiello P
Acta Diabetol; 2014 Feb; 51(1):113-21. PubMed ID: 24121871
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
6. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
[TBL] [Abstract][Full Text] [Related]
7. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility.
Capasso R; Borrelli F; Aviello G; Capasso F; Izzo AA
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):407-14. PubMed ID: 18172613
[TBL] [Abstract][Full Text] [Related]
9. Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin.
Novelli M; Beffy P; Gregorelli A; Porozov S; Mascia F; Vantaggiato C; Masiello P; Menegazzi M
J Pharm Pharmacol; 2019 Jan; 71(1):93-103. PubMed ID: 28990659
[TBL] [Abstract][Full Text] [Related]
10. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
[TBL] [Abstract][Full Text] [Related]
11. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
12. Hyperforin Elicits Cytostatic/Cytotoxic Activity in Human Melanoma Cell Lines, Inhibiting Pro-Survival NF-κB, STAT3, AP1 Transcription Factors and the Expression of Functional Proteins Involved in Mitochondrial and Cytosolic Metabolism.
Cardile A; Zanrè V; Campagnari R; Asson F; Addo SS; Orlandi E; Menegazzi M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674794
[TBL] [Abstract][Full Text] [Related]
13. Hyperforin in St. John's wort drug interactions.
Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
Wonnemann M; Singer A; Siebert B; Müller WE
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
[TBL] [Abstract][Full Text] [Related]
15. Hypericum perforatum L. (St John's wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment?
Ruedeberg C; Wiesmann UN; Brattstroem A; Honegger UE
Phytother Res; 2010 Feb; 24(2):249-51. PubMed ID: 19585471
[TBL] [Abstract][Full Text] [Related]
16. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
17. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
[TBL] [Abstract][Full Text] [Related]
18. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of alcohol intake by extract of Hypericum perforatum (St. John's Wort) in two different strains of alcohol-preferring rats.
Rezvani AH; Overstreet DH; Yang Y; Clark E
Alcohol Alcohol; 1999; 34(5):699-705. PubMed ID: 10528812
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
